0
     

Report Added
Report already added
Microbiomes Market in China - Industry Outlook and Forecast 2020-2026

Microbiomes Market in China - Industry Outlook and Forecast 2020-2026

This report contains market size and forecasts of Microbiomes in China, including the following market information:
China Microbiomes Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in China Microbiomes Market 2019 (%)
The global Microbiomes market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Microbiomes market size in China was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
Total Market by Segment:
China Microbiomes Market, By Type, 2015-2020, 2021-2026 ($ millions)
China Microbiomes Market Segment Percentages, By Type, 2019 (%)
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other

China Microbiomes Market, By Application, 2015-2020, 2021-2026 ($ millions)
China Microbiomes Market Segment Percentages, By Application, 2019 (%)
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Microbiomes Market Competitors Revenues in China, by Players 2015-2020 (Estimated), ($ millions)
Total Microbiomes Market Competitors Revenues Share in China, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc
1 Introduction to Research & Analysis Reports
1.1 Microbiomes Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 China Microbiomes Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 China Microbiomes Overall Market Size
2.1 China Microbiomes Market Size: 2020 VS 2026
2.2 China Microbiomes Revenue, Prospects & Forecasts: 2015-2026

3 Company Landscape
3.1 Top Microbiomes Players in China (including Foreign and Local Companies)
3.2 Top China Microbiomes Companies Ranked by Revenue
3.3 China Microbiomes Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Microbiomes Companies in China, by Revenue in 2019
3.5 China Manufacturers Microbiomes Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microbiomes Players in China
3.6.1 List of China Tier 1 Microbiomes Companies
3.6.2 List of China Tier 2 and Tier 3 Microbiomes Companies

4 Market Sights by Product
4.1 Overview
4.1.1 By Type - China Microbiomes Market Size Markets, 2020 & 2026
4.1.2 Gastrointestinal Microbiome
4.1.3 Genitourinary Microbiome
4.1.4 Skin Microbiome
4.1.5 Respiratory Microbiome
4.1.6 Other
4.2 By Type - China Microbiomes Revenue & Forecasts
4.2.1 By Type - China Microbiomes Revenue, 2015-2020
4.2.2 By Type - China Microbiomes Revenue, 2021-2026
4.2.3 By Type - China Microbiomes Revenue Market Share, 2015-2026
5 Market Sights by Application
5.1 Overview
5.1.1 By Application - China Microbiomes Market Size, 2020 & 2026
5.1.2 Testing
5.1.3 Treatment
5.1.4 Diagnosis
5.1.5 Technology Platform
5.1.6 Probiotics
5.1.7 Other
5.2 By Application - China Microbiomes Revenue & Forecasts
5.2.1 By Application - China Microbiomes Revenue, 2015-2020
5.2.2 By Application - China Microbiomes Revenue, 2021-2026
5.2.3 By Application - China Microbiomes Revenue Market Share, 2015-2026
6 Players Profiles
6.1 4D Pharma
6.1.1 4D Pharma Corporate Summary
6.1.2 4D Pharma Business Overview
6.1.3 4D Pharma Microbiomes Major Product Offerings
6.1.4 4D Pharma Revenue in China (2015-2020)
6.1.5 4D Pharma Key News
6.2 Enterome BioScience
6.2.1 Enterome BioScience Corporate Summary
6.2.2 Enterome BioScience Business Overview
6.2.3 Enterome BioScience Microbiomes Major Product Offerings
6.2.4 Enterome BioScience Revenue in China (2015-2020)
6.2.5 Enterome BioScience Key News
6.3 Evelo Biosciences
6.3.1 Evelo Biosciences Corporate Summary
6.3.2 Evelo Biosciences Business Overview
6.3.3 Evelo Biosciences Microbiomes Major Product Offerings
6.3.4 Evelo Biosciences Revenue in China (2015-2020)
6.3.5 Evelo Biosciences Key News
6.4 Ferring
6.4.1 Ferring Corporate Summary
6.4.2 Ferring Business Overview
6.4.3 Ferring Microbiomes Major Product Offerings
6.4.4 Ferring Revenue in China (2015-2020)
6.4.5 Ferring Key News
6.5 Osel
6.5.1 Osel Corporate Summary
6.5.2 Osel Business Overview
6.5.3 Osel Microbiomes Major Product Offerings
6.5.4 Osel Revenue in China (2015-2020)
6.5.5 Osel Key News
6.6 Second Genome
6.6.1 Second Genome Corporate Summary
6.6.2 Second Genome Business Overview
6.6.3 Second Genome Microbiomes Major Product Offerings
6.6.4 Second Genome Revenue in China (2015-2020)
6.6.5 Second Genome Key News
6.7 Seres Therapeutics
6.6.1 Seres Therapeutics Corporate Summary
6.6.2 Seres Therapeutics Business Overview
6.6.3 Seres Therapeutics Microbiomes Major Product Offerings
6.4.4 Seres Therapeutics Revenue in China (2015-2020)
6.7.5 Seres Therapeutics Key News
6.8 Synlogic
6.8.1 Synlogic Corporate Summary
6.8.2 Synlogic Business Overview
6.8.3 Synlogic Microbiomes Major Product Offerings
6.8.4 Synlogic Revenue in China (2015-2020)
6.8.5 Synlogic Key News
6.9 Synthetic Biologics and Vedanta Biosciences
6.9.1 Synthetic Biologics and Vedanta Biosciences Corporate Summary
6.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
6.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Major Product Offerings
6.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in China (2015-2020)
6.9.5 Synthetic Biologics and Vedanta Biosciences Key News
6.10 Vedanta
6.10.1 Vedanta Corporate Summary
6.10.2 Vedanta Business Overview
6.10.3 Vedanta Microbiomes Major Product Offerings
6.10.4 Vedanta Revenue in China (2015-2020)
6.10.5 Vedanta Key News
6.11 Rebiotix
6.11.1 Rebiotix Corporate Summary
6.11.2 Rebiotix Microbiomes Business Overview
6.11.3 Rebiotix Microbiomes Major Product Offerings
6.11.4 Rebiotix Revenue in China (2015-2020)
6.11.5 Rebiotix Key News
6.12 ActoGeniX
6.12.1 ActoGeniX Corporate Summary
6.12.2 ActoGeniX Microbiomes Business Overview
6.12.3 ActoGeniX Microbiomes Major Product Offerings
6.12.4 ActoGeniX Revenue in China (2015-2020)
6.12.5 ActoGeniX Key News
6.13 Enterologics
6.13.1 Enterologics Corporate Summary
6.13.2 Enterologics Microbiomes Business Overview
6.13.3 Enterologics Microbiomes Major Product Offerings
6.13.4 Enterologics Revenue in China (2015-2020)
6.13.5 Enterologics Key News
6.14 Metabogen
6.14.1 Metabogen Corporate Summary
6.14.2 Metabogen Microbiomes Business Overview
6.14.3 Metabogen Microbiomes Major Product Offerings
6.14.4 Metabogen Revenue in China (2015-2020)
6.14.5 Metabogen Key News
6.15 Metabiomics
6.15.1 Metabiomics Corporate Summary
6.15.2 Metabiomics Microbiomes Business Overview
6.15.3 Metabiomics Microbiomes Major Product Offerings
6.15.4 Metabiomics Revenue in China (2015-2020)
6.15.5 Metabiomics Key News
6.16 Ritter Pharmaceuticals
6.16.1 Ritter Pharmaceuticals Corporate Summary
6.16.2 Ritter Pharmaceuticals Microbiomes Business Overview
6.16.3 Ritter Pharmaceuticals Microbiomes Major Product Offerings
6.16.4 Ritter Pharmaceuticals Revenue in China (2015-2020)
6.16.5 Ritter Pharmaceuticals Key News
6.17 AvidBiotics
6.17.1 AvidBiotics Corporate Summary
6.17.2 AvidBiotics Microbiomes Business Overview
6.17.3 AvidBiotics Microbiomes Major Product Offerings
6.17.4 AvidBiotics Revenue in China (2015-2020)
6.17.5 AvidBiotics Key News
6.18 Symberix
6.18.1 Symberix Corporate Summary
6.18.2 Symberix Microbiomes Business Overview
6.18.3 Symberix Microbiomes Major Product Offerings
6.18.4 Symberix Revenue in China (2015-2020)
6.18.5 Symberix Key News
6.19 Miomics
6.19.1 Miomics Corporate Summary
6.19.2 Miomics Microbiomes Business Overview
6.19.3 Miomics Microbiomes Major Product Offerings
6.19.4 Miomics Revenue in China (2015-2020)
6.19.5 Miomics Key News
6.20 Symbiotix Biotherapies
6.20.1 Symbiotix Biotherapies Corporate Summary
6.20.2 Symbiotix Biotherapies Microbiomes Business Overview
6.20.3 Symbiotix Biotherapies Microbiomes Major Product Offerings
6.20.4 Symbiotix Biotherapies Revenue in China (2015-2020)
6.20.5 Symbiotix Biotherapies Key News
6.21 MicroBiome Therapeutics LLC
6.21.1 MicroBiome Therapeutics LLC Corporate Summary
6.21.2 MicroBiome Therapeutics LLC Microbiomes Business Overview
6.21.3 MicroBiome Therapeutics LLC Microbiomes Major Product Offerings
6.21.4 MicroBiome Therapeutics LLC Revenue in China (2015-2020)
6.21.5 MicroBiome Therapeutics LLC Key News
6.22 SciBac Inc
6.22.1 SciBac Inc Corporate Summary
6.22.2 SciBac Inc Microbiomes Business Overview
6.22.3 SciBac Inc Microbiomes Major Product Offerings
6.22.4 SciBac Inc Revenue in China (2015-2020)
6.22.5 SciBac Inc Key News

7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for China Microbiomes Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 Conclusion

9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 DisclaimerList of Tables
Table 1. Key Players of Microbiomes in China
Table 2. Top Players in China, Ranking by Revenue (2019)
Table 3. China Microbiomes Revenue by Companies, (US$, Mn), 2015-2020
Table 4. China Microbiomes Revenue Share by Companies, 2015-2020
Table 5. China Microbiomes Sales by Companies, (K Units), 2015-2020
Table 6. China Microbiomes Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Microbiomes Price (2015-2020) (US$/Unit)
Table 8. China Manufacturers Microbiomes Product Type
Table 9. List of China Tier 1 Microbiomes Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of China Tier 2 and Tier 3 Microbiomes Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Microbiomes Revenue in China (US$, Mn), 2015-2020
Table 12. By Type - Microbiomes Revenue in China (US$, Mn), 2021-2026
Table 13. By Type - Microbiomes Sales in China (K Units), 2015-2020
Table 14. By Type - Microbiomes Sales in China (K Units), 2021-2026
Table 15. By Application - Microbiomes Revenue in China, (US$, Mn), 2015-2020
Table 16. By Application - Microbiomes Revenue in China, (US$, Mn), 2021-2026
Table 17. By Application - Microbiomes Sales in China, (K Units), 2015-2020
Table 18. By Application - Microbiomes Sales in China, (K Units), 2021-2026
Table 19. 4D Pharma Corporate Summary
Table 20. 4D Pharma Microbiomes Product Offerings
Table 21. 4D Pharma Microbiomes Revenue (US$, Mn), (2015-2020)
Table 22. Enterome BioScience Corporate Summary
Table 23. Enterome BioScience Microbiomes Product Offerings
Table 24. Enterome BioScience Microbiomes Revenue (US$, Mn), (2015-2020)
Table 25. Evelo Biosciences Corporate Summary
Table 26. Evelo Biosciences Microbiomes Product Offerings
Table 27. Evelo Biosciences Microbiomes Revenue (US$, Mn), (2015-2020)
Table 28. Ferring Corporate Summary
Table 29. Ferring Microbiomes Product Offerings
Table 30. Ferring Microbiomes Revenue (US$, Mn), (2015-2020)
Table 31. Osel Corporate Summary
Table 32. Osel Microbiomes Product Offerings
Table 33. Osel Microbiomes Revenue (US$, Mn), (2015-2020)
Table 34. Second Genome Corporate Summary
Table 35. Second Genome Microbiomes Product Offerings
Table 36. Second Genome Microbiomes Revenue (US$, Mn), (2015-2020)
Table 37. Seres Therapeutics Corporate Summary
Table 38. Seres Therapeutics Microbiomes Product Offerings
Table 39. Seres Therapeutics Microbiomes Revenue (US$, Mn), (2015-2020)
Table 40. Synlogic Corporate Summary
Table 41. Synlogic Microbiomes Product Offerings
Table 42. Synlogic Microbiomes Revenue (US$, Mn), (2015-2020)
Table 43. Synthetic Biologics and Vedanta Biosciences Corporate Summary
Table 44. Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offerings
Table 45. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue (US$, Mn), (2015-2020)
Table 46. Vedanta Corporate Summary
Table 47. Vedanta Microbiomes Product Offerings
Table 48. Vedanta Microbiomes Revenue (US$, Mn), (2015-2020)
Table 49. Rebiotix Corporate Summary
Table 50. Rebiotix Microbiomes Product Offerings
Table 51. Rebiotix Microbiomes Revenue (US$, Mn), (2015-2020)
Table 52. ActoGeniX Corporate Summary
Table 53. ActoGeniX Microbiomes Product Offerings
Table 54. ActoGeniX Microbiomes Revenue (US$, Mn), (2015-2020)
Table 55. Enterologics Corporate Summary
Table 56. Enterologics Microbiomes Product Offerings
Table 57. Enterologics Microbiomes Revenue (US$, Mn), (2015-2020)
Table 58. Metabogen Corporate Summary
Table 59. Metabogen Microbiomes Product Offerings
Table 60. Metabogen Microbiomes Revenue (US$, Mn), (2015-2020)
Table 61. Metabiomics Corporate Summary
Table 62. Metabiomics Microbiomes Product Offerings
Table 63. Metabiomics Microbiomes Revenue (US$, Mn), (2015-2020)
Table 64. Ritter Pharmaceuticals Corporate Summary
Table 65. Ritter Pharmaceuticals Microbiomes Product Offerings
Table 66. Ritter Pharmaceuticals Microbiomes Revenue (US$, Mn), (2015-2020)
Table 67. AvidBiotics Corporate Summary
Table 68. AvidBiotics Microbiomes Product Offerings
Table 69. AvidBiotics Microbiomes Revenue (US$, Mn), (2015-2020)
Table 70. Symberix Corporate Summary
Table 71. Symberix Microbiomes Product Offerings
Table 72. Symberix Microbiomes Revenue (US$, Mn), (2015-2020)
Table 73. Miomics Corporate Summary
Table 74. Miomics Microbiomes Product Offerings
Table 75. Miomics Microbiomes Revenue (US$, Mn), (2015-2020)
Table 76. Symbiotix Biotherapies Corporate Summary
Table 77. Symbiotix Biotherapies Microbiomes Product Offerings
Table 78. Symbiotix Biotherapies Microbiomes Revenue (US$, Mn), (2015-2020)
Table 79. MicroBiome Therapeutics LLC Corporate Summary
Table 80. MicroBiome Therapeutics LLC Microbiomes Product Offerings
Table 81. MicroBiome Therapeutics LLC Microbiomes Revenue (US$, Mn), (2015-2020)
Table 82. SciBac Inc Corporate Summary
Table 83. SciBac Inc Microbiomes Product Offerings
Table 84. SciBac Inc Microbiomes Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Microbiomes Segment by Type
Figure 2. Microbiomes Segment by Application
Figure 3. China Microbiomes Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Microbiomes Market Size in China, (US$, Mn): 2020 VS 2026
Figure 6. China Microbiomes Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Microbiomes Revenue in 2019
Figure 8. By Type - China Microbiomes Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - China Microbiomes Market Share, 2015-2026
Figure 10. By Application - Microbiomes Revenue in China (US$, Mn), 2020 & 2026
Figure 11. By Application - China Microbiomes Market Share, 2015-2026
Figure 12. PEST Analysis for China Microbiomes Market in 2020
Figure 13. Microbiomes Market Opportunities & Trends in China
Figure 14. Microbiomes Market Drivers in China

Report Title: Microbiomes Market in China - Industry Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW